Health Care Choices, Inc.
presents
November 3, 1997
New York City
Sponsored by:
Empire Blue Cross and Blue Shield
Medical Society of the State of New York
Proskauer Rose LLP
Towers Perrin
William M. Mercer
Conference Agenda: Clinical Research and Experimental
Treatments: Who Participates and Who Pays?
8:30 a.m. - 9:00 a.m.
- Registration and Continental Breakfast donated by the HMO Council of New York
9:00 a.m. - 9:10 a.m.
- Welcome by
Susan Rosenfeld, Esq.
President, Health Care
Choices, Inc.
9:10 a.m. - 10:10 a.m.
- Keynote Address
Healthcare Fraud and the Waste of Resources
Lewis Morris, Esq.
Assistant Inspector General
Office of Inspector General
Department of
Health and Human Services
10:10 a.m. - 10:30 a.m. Break
10:30 a.m. - 12:00 noon
- Should Health Insurance Cover
Experimental Treatments?
Moderator:
James R. Tallon, Jr.
President
United Hospital Fund of New York
Panel:
Clifford A. Hudis, MD
Assistant Attending Physician
Memorial
Sloan-Kettering Cancer Center
Larry Kramer
Co-Founder
Gay Men's Health Crisis
Elliott Shaw
Director of Government Affairs
The Business Council
of New York State, Inc.
Michael A. Stocker, MD
President and Chief Executive Officer
Empire
Blue Cross and Blue Shield
Topics include:
- What are the factors which can affect the cost of experimental treatments?
- How do patients benefit from participation in research?
- Are there benefits to employers from providing insurance coverage for experimental
treatments?
- What are the long term implications of providing, and not providing, insurance coverage
for experimental treatments?
12:00 noon - 1:30 p.m. Buffet Luncheon
1:30 p.m. - 3:30 p.m.
Clinical Research and the Development
of Experimental Treatments
Charles N. Aswad, MD
Executive Vice President
Medical Society of the State of New York
Panel:
Peter G. Goldschmidt, MD, DrPH, DMS
President
Medical Care Management Corporation
Arthur L. Levin, MD
Vice President
Technology and Clinical Practice Assessment
Prudential HealthCare
Mary S. McCabe, RN
Director
Office of Clinical Research Promotion
National Cancer
Institute
Charles Vogel, MD
Director
Columbia Cancer Research Network of Florida
Paula Waterman, MS
Executive Director
Institutional Review Board
Food and Drug
Administration
Topics include:
- Who does clinical research?
- How are experimental treatments developed?
- What studies have been undertaken to identify the costs of clinical research?
- Who regulates clinical research and experimental treatments?
- Who pays for clinical research and experimental treatments?
Health Care Choices Main Page | Who We Are/Contact Us
Newsletter | Information
About Health Care Providers
Insurance Information
Programs and Studies | Search |
